Patients with IMIDs who had IMMs prescriptions had higher RR across adverse pregnancy outcomes than patients with IMIDs who did not have IMMs prescriptions, but these associations did not reach statistical significance.
← all excerpts
Maternal-fetal outcomes in patients with immune-mediated inflammatory diseases, with consideration of comorbidities: a retrospective cohort study in a large U.S. healthcare system.
1
—
—